Frequently Asked Questions
The global cell counting market was valued at USD 8548.9 Million in 2022.
The cell counting market is expected to grow at a CAGR of 8.8% between 2023 and 2030, reaching USD 16785.8 Million in 2030.
Automated cell counting is the leading segment by technology, holding over 42% share in value in 2022.
The reagents & consumables segment governs the global demand for cell counting, holding a massive market share of over 35% in 2022.
The mammalian cells segment will post the highest CAGR over the projection period.
North America contributes to the rapid growth of the cell counting industry, accounting for more than one-third of its market share in 2022.
The top players include Merck KGaA, ThermoFisher Scientific Inc., PerkinElmer Inc., Agilent Technologies, Danaher, BD, Bio-Rad Laboratories Inc., GE Healthcare, BioTek Instruments Inc., DeNovix Inc., and Others.
The major market drivers are the increasing applications in biomedical research and healthcare, as well as continuous technological advancements in cell counting methods and instruments.
The major market restraints encompass higher initial investment and operational costs associated with highly advanced technologies and the complexity and standardization challenges in heterogeneous samples.
Major market opportunities lie in the growth of point-of-care and decentralized testing with portable cell counters and the integration of artificial intelligence (AI) and automation to enhance accuracy and streamline workflows.